Figure 4.

Changes in the levels of circulating GLK-expressing T-cells, the expression levels of GLK proteins as well as transcripts, and serum levels of soluble interleukin-2 receptor in 12 patients with adult-onset Still's disease after effective therapy. Data are presented as mean ± standard error of the mean. *P <0.005 versus before treatment, determined by the Wilcoxon signed rank test. AOSD: adult-onset Still's disease; GLK: germinal center kinase-like kinase; sIL-2R: soluble interleukin-2 receptor.